Blepharitis Market to Witness an Outstanding Growth by 2023

 Blepharitis Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

Blepharitis Market Research Report: Type (Anterior Blepharitis, Posterior Blepharitis, Mixed Blepharitis) Treatment (Eye Cleansers, Antibiotic Therapy) Diagnosis (Physical Examination) End User (Hospitals, Specialty Centers) – Global forecast till 2023           

Blepharitis is a common condition of ophthalmologic disorder. The disorder causes inflammation of the eyelids, which leads to irritation in the eyes. It is caused by either bacteria or skin related conditions like dandruff or oil overproduction from the glands of the eyelids. The global blepharitis market is projected to attain a CAGR of 6.5% during the assessment period.

Also Read : https://www.medgadget.com/2019/04/blepharitis-market-size-share-solid-analyzed-segmentation-recent-trends-and-growth-prospects-by-regions-to-2023.html 

The market is primarily driven by the surging prevalence of ophthalmological ailments like uveitis, dry eye, and others. Other factors influencing a positive demand on the market are rising demand for advanced form of treatments, favorable government initiatives, emergence of market players offering various new products for blepharitis treatment, and increasing awareness concerning eye care are all expected to likely drive the blepharitis market. Additionally, the involvement of various important players in upgrading their existing products and development of new products is also believed to boost the global blepharitis market.

Global Blepharitis Market is expected to grow at a CAGR of 6.5% during the forecast period.

Key Players for Global Blepharitis Market

Some of the leading players in the global blepharitis market are Scope Ophthalmics Ltd, NovaBay Pharmaceuticals, Inc., Merck & Co., InSite Vision Incorporated, Galderma S.A., Perrigo Laboratories, Thea Pharmaceuticals Limited, and Novartis AG.

March 14^th, 2019, Bruder announced in a press release about the launch of its two dry eye products, named Eyeleve Contact Lens Compress and Bruder Hygienic Eyelid Solution. The solutions are said to be safe and secure for daily and long-term use for patients suffering with conditions such as meibomian glan dysfunction and blepharitis.

March 7^th, 2019, it was announced by Sight Science at SECO 2019 that they might be launching their new technology for applying heat to the eyelids this May. The product is named as TearCare.

Segments for Global Blepharitis Market

The global blepharitis market segmentation is done in the following basis: end-user, treatment, type, and diagnosis.

By type, the market includes posterior blepharitis, anterior blepharitis, and mixed blepharitis.

By end-users, the market comprises of hospitals, specialty centers, and others.

By treatment, the market is antibiotic therapy, eye cleansers, and artificial tears. The antibiotic therapy segment is narrowed down into oral antibiotic therapy and topical antibiotic therapy.

By diagnosis, the market is classified into comprehensive eye examination, physical examination, and others.

Regional Analysis for Global Blepharitis Market

The geographical segmentation of the global blepharitis market covers the Americas, Europe, Asia Pacific, and the Middle East & Africa region.

North America is the market leader in blepharitis in the global standings. The Americas region is segmented into two contributors, namely South and North America. In North America, the maximum percentage of the contribution is attributed to the US and Canada. Here, increasing prevalence of eye disorders coupled with the growing awareness among the consumers concerning the need for proper eye care is likely to push the market growth. Add to this, the increasing involvement of various leading players in the market, rising support from the government, and the growing expenditure in the healthcare sector are some of the other factors that are likely to enhance the blepharitis market.

Standing tall with the second largest market share, Europe holds a healthy presence in the global blepharitis market. The market in this region is anticipated to witness decent growth during the forecast period due to various reasons. This includes, the presence of a large pool of market players that are offering effective and innovative products, rising number of skilled medical professionals, and a surging demand for improved and advanced healthcare infrastructure.

Asia Pacific region is said to be potentially the fastest growing market in the globe. Herein, rising prevalence of eye-related disorders and growing patient population are slated to be the major market drivers.

The Middle East and African region is expected to experience the least growth percentage due to significant market constraints like lack of awareness concerning the disease and limited treatment facilities. However, the United Arab Emirates (UAE) region is the largest market share holder under the MEA region due to continuous development of the healthcare sector and growing demand for various advanced specialty centers.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/blepharitis-market-5766

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Ceramics Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

 Medical Ceramics Market report by MRFR contains all analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry.

Medical Ceramics Market Information: By Type (Bioinert Ceramics and Bioactive Ceramics), by Application (Dental, Orthopedic, Plastic Surgery, Diagnostic Instruments, and Cardiovascular), and End-User (Hospitals and Clinics and Specialty Centers) – Global Forecast Till 2023

Key Players :

Notable players mentioned in the Medical Ceramics Market, as described in the report published by MRFR, are Zimmer Holdings, Inc, CoorsTek Inc., Stryker, Straumann, H.C. Starck GmbH, Kyocera Corporation, 3M ESPE, Morgan Advanced Materials, Nobel Biocare Services AG, and DePuy Synthes.

Also Read : https://www.medgadget.com/2019/04/global-medical-ceramics-market-trends-demand-and-opportunities-with-industry-size-and-share-analysis-by-kyocera-corporation-3m-espe-stryker-etc-till-2023.html 

In 2018, researchers from the City University of Hong Kong (CityU) had successfully developed a method to develop 4D printed medical ceramic products which would be robust in their construction and can provide complex shapes. The important factor that would trigger the technology is the ceramic ink that is a combination of polymers and ceramic nanoparticles.

Medical Ceramics Market – Overview

The Global Medical Ceramics Market is expected, as per Market Research Future (MRFR) reports, to rise by 6.5% CAGR over the forecast period (2017-2023). It can also achieve substantial market valuation by the end of 2023. Medical ceramics find substantial percolation in the healthcare sector. Its applications as implants, prosthetics, and medical tools & devices are quite riveting. Mostly these equipment are sourced from alumina and zirconia. Among other uses,  pacemakers, kidney dialysis machines, and respirators are keeping the medical ceramics market quite engaged. Medical ceramics are getting quite popular owing to their abrasion resistance and inert nature inside the human body. These properties are providing considerable traction to the market as bone replacements and dental implants. MRFR report on the medical ceramics market included segmental analysis, both volume-wise and value-wise. At the same time, factors that can influence the market in the coming years are also included in the report.

The Medical Ceramics Market is getting traction from several healthcare departments such as cardiology and dental. Its features are making it an easy-to-approach option for these segments. But, mostly, the medical ceramics market is enjoying rising investment from both government and private bodies which can also curb the effects of high cost of the procedures. These initiatives can ensure substantial growth for the market in the coming years.

Regional Analysis :

The North America medical Ceramics market backed by the presence of matured players and substantial investments is estimated to account for the leading market, globally, holding the largest market share. Also, companies involved in the manufacturing of these ceramics are well capable of delivering a range of customized solutions.

Owing to the augmented uptake of software solutions for healthcare administration and availability of complimenting resources, the market is projected to create a large revenue pocket during the forecast period.

Additional factors substantiating the market growth in the region include increasing number of patients suffering from chronic diseases & disorders that eventually augment the demand for technologically advanced treatments and products along with rising government support, growing demand for the ceramics for medical use.

Globally, Europe region stands as the second largest market for the medical ceramics. Extensive technological advancements and the augmented adoption of advanced ceramics among the healthcare providers mainly in the UK, Germany, and France coupled with the resurging economy in the region fosters the market growth in the region. Also, the rising cases of dental disorders along with rising population awareness towards the health are promoting the growth of the medical ceramics market in the region.

The Asia Pacific region is rapidly emerging as one of the lucrative markets for the medical ceramics. Moreover, factors such as, increasing incidences of recorded chronic diseases, availability of new treatment methods, and the ever-increasing population that is increasingly gaining awareness towards the benefits of health management, foster the market growth in the region.  Besides rising government support and improving per capita health care expenditures are positively impacting the market growth in the region.

Segmentation :

MRFR in their report segments the Medical Ceramics Market by type, application, and end-user for a holistic analysis.

Based on the type, the medical ceramics market is segmented into bioactive ceramics, piezoceramics, bioinert ceramics, and bioresorbable ceramics. The bioinert ceramics segment includes zirconia, alumina, and others. The bioactive ceramics comprises hydroxyapatite and glass ceramics.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/medical-ceramics-market-5729

Based on the application, the medical ceramics market includes cardiovascular, diagnostic instruments, dental, plastic surgery, orthopedic, surgical instruments, and others. The dental segment consists dental implants, dental crowns & bridges, inlays & onlays, braces, and dental bone grafts & substitutes. The orthopedic segment is sub-segmented into a joint replacement, fracture fixation, and orthobiologics. The joint replacement segment includes knee replacement, shoulder replacement, hip replacement, and others.

Based on the end-user, the medical ceramics market comprises specialty centers, hospitals and clinics, and research centers.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Blood Transfusion Diagnostics Market – Product Development is the best strategy for market position; Forecast till 2023

 Blood Transfusion Diagnostics Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

The Global Blood Transfusion Diagnostics Market is expected to rise to valuation of USD 2.45 billion by 2023, rising at a CAGR of 8.2% over its 2016 value of USD 1.5 billion, according to the latest research report from Market Research Future (MRFR). The global blood transfusion diagnostics market is mainly driven by the growing demand for blood transfusions and the growing demand for ensuring safe blood transfusions. The global blood transfusion diagnostics market is assessed in great detail in the report, which provides a thorough review of the market’s key drivers and restraints, leading segments, and major market players.

Also Read : https://www.medgadget.com/2019/08/blood-transfusion-diagnostics-market-2019-global-growth-status-share-demand-size-business-insights-and-region-wise-forecast-to-2023.html 

The global blood transfusion diagnostics market is mainly driven by the growing demand for blood transfusions. The blood transferred during blood transfusions has to be checked for diseases before being transferred to another patient, as bloodborne diseases can be contracted by the recipient. This has led to a growing demand for strong blood transfusion diagnostics infrastructure. In developed regions, the blood transfusion diagnostics infrastructure is widespread and strong due to the high number of blood transfusion procedures carried out in these regions. The receiver of the blood as well as the medical staff are susceptible to diseases contained in donated blood, making it likely that the blood transfusion diagnostics market will grow at a stable growth rate over the forecast period.

The increasing prevalence of infectious diseases and the growing awareness about the need for effective blood transfusion diagnostics are also likely to be major drivers for the global blood transfusion diagnostics market over the forecast period. Infectious diseases are a major concern for the global healthcare sector, making it likely that the global blood transfusion diagnostics market will receive stable government support over the coming years, leading to steady growth of the market.

Industry News:

In June 2019, Dubai Health Authority (DHA) announced the launch of its blood donation campaign, ‘Be the Hero … Save Lives’ for encouraging donators and creating awareness.

In June 2019, The American Chamber of Commerce in Việt Nam (AmCham Vietnam) collaborated with HCM City Institute of Hematology, and Blood Transfusion organized a blood donation campaign to celebrate the World’s Blood Donor Day on 14^th of the month.

In February 2019, a two year old in the Tamil Nadu state of India was alleged to have contracted HIV from a blood transfusion. Further enquiries cleared the hospital staff of any wrongdoing, as the source of the HIV was ascertained to be something other than the transfusion. Such incidents reveal the need for strong blood transfusion diagnostics infrastructure, especially in emerging countries.

In January 2019, a leader in transfusion and transplantation diagnostics, Immucor, Inc., has announced that it has received approval from Health Canada for its next-gen fully automated Echo® instrument, Echo LumenaTM.

Key Players for Global Blood Transfusion Diagnostics Market

The prominent players participating in the share assessment of the global blood transfusion diagnostics market are Thermo Fisher Scientific, Inc. (U.S.), Grifols (Spain), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), BioMérieux (France), Immucor (U.SOrtho Clinical Diagnostics, Inc. (U.S.), ),  Becton, Dickinson and Company (U.S.), Siemens Healthineers (Germany), Beckman Coulter, Inc. (U.S.), Novartis AG (Switzerland), Ortho Clinical Diagnostics (U.S), Diagast (France), Abbott Diagnostics (U.S), Beckman Coulter (U.S), BAG healthcare (Germany),  Fujirebio (Belgium), DiaSorin (Italy), Grifols (Spain), Hologic/Gen-Probe (U.S), Quidel (U.S), and Biokit (Spain).

Segments for Global Blood Transfusion Diagnostics Market

The global blood transfusion diagnostics market, on the basis of blood product, has been segmented into platelets, red blood cells, plasma, immunoglobulin preparations, albumin, and other products.

Based on technology, the blood transfusion diagnostics market has been segmented into ELISA, nucleic acid amplification, rapid test, western blot, fluorescence assay, and others. The ELISA segment has been sub-segmented into fluorescence immunoassays (FIA), chemiluminescence immunoassay (CLIA), and colorimetric immunoassay (CI). The nucleic acid amplification segment is sub-divided into Thermomechanical analysis (TMA) and real-time PCR.

By end-users, the global blood transfusion diagnostics market has been segmented into clinics, blood banks, hospitals, laboratories.

Regional Analysis for Global Blood Transfusion Diagnostics Market

The global blood transfusion diagnostics market, on the basis of region, has been segmented into four key regions, viz. Europe, Asia Pacific, Americas, and the Middle East and Africa (MEA). Americas is prognosticated to account for the maximum market share in the forthcoming years. The growth can be ascribed to the rising adoption of nucleic acid amplification test. In addition, the increasing count of road accidents is also poised to favor market growth in the region. Europe is in the second spot and is likely to grow significantly over the next couple of years. The rising awareness about blood donation and investments in blood donation campaigns are anticipated to boost revenue generation for the market players. Asia Pacific is also prognosticated to exhibit rapid developments. The exponential population growth of the region is likely to benefit the growth pattern of the blood transfusion diagnostics market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Cardiac Pacemaker Market Estimated to Witness a Staggering Growth by 2023

 Global Cardiac Pacemaker Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

MRFR is the Leading Brand in The Research Company Who Recently Published Global Cardiac Pacemaker Market Research Reports which includes Study of Growth Overview, Regional Analysis, Top Players, Major Drivers, Upcoming Trends and Foreseen to 2023

Prominent names in the Global Cardiac Pacemaker Market are Medtronic (U.S.), Abbott. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK (Germany), LEPU MEDICAL (U.K), SORIN Group (Europe), MEDICO S.p.A. (Europe), OSCOR Inc. (U.S.), and others.

Also Read : https://www.medgadget.com/2019/09/cardiac-pacemaker-market-insights-2019-competitive-players-size-value-demand-regional-outlook-type-technology-restrains-and-foreseen-by-mrfr-till-2023.html 

Market Overview:

The Global Cardiac Pacemaker Market is expecting a 7.9% CAGR during the forecast period (2017-2023) to claim substantial market valuation by the end of 2023, asserts Market Research Future (MRFR). This certain growth can be attributed to several factors from its functional features to its use in countering diverse health-related issues. Cardiac pacemaker’s use in maintaining regularity of the heart rhythm by sending electrical pulses to the heart has gained traction in treating atrial fibrillation (AFib) which is also the chief driver in taking the cardiac pacemaker market ahead. Furthermore, the rising geriatric population, with a predicted number of 2.1billion by 2050, is expanding the cardiac pacemaker market horizon.

However, cardiac pacemakers incur high cost which can be a hurdle for the cardiac pacemaker market during the forecast period. At the same time, its implantation procedure requires surgery and risks of malfunctioning can add further woe.

Industry Trend:

Researchers at the University of Ottawa Heart Institute completed the first successful implant in 2018 of a Micra Leadless Transcatheter Pacing System, which is the latest model of its category and the smallest leadless pacemaker in the world. The process allows the machine to be implanted directly within the heart, unlike other pacemakers.

Practitioners at Children’s Hospital Los Angeles and the University of Southern California have developed a micropacemaker system requiring implantation in the pericardial sac which could be a breakthrough in cardiac surgery options for children and adults.

Segment Analysis

The global cardiac pacemaker market can be segmented by type, technology, application, and end-users.

Based on type, the cardiac pacemaker market includes implantable, external cardiac pacemaker, and others.

Technology-wise, the cardiac pacemaker market comprises biventricular, single-chambered, dual-chambered, and others.

Application-based segmentation of the cardiac pacemaker market consists arrhythmias, congestive heart failure, and others. Arrhythmias segment can be sub-segmented into tachycardia, bradycardia, and others.

Based on the end-users, the market cardiac pacemaker includes hospitals, cardiac care centers, medical institutes, and others.

Regional Analysis

Geographical analysis of cardiac pacemaker market includes regions namely the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas has the lead in the global market, and they can attribute this to a superior infrastructure, and better healthcare policies. Furthermore, a considerable patient pool is also playing in favor of cardiac pacemaker market. Changing lifestyle and high healthcare expenditure are proving essential for the regional market growth.

Europe is following the lead and is experiencing considerable growth owing to regular investment in research and development. Governments taking a keen interest in the sector has a positive impact on the market.

The APAC is the fastest growing region with India and China continually improving their industrial landscape. In addition, many countries of this region are emerging as a medical tourism hub and helping the regional cardiac pacemaker market witness unprecedented growth. The MEA region’s growth will be slow due to lack of infrastructure and poor economic regions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/cardiac-pacemaker-market-2025

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Global Robotics Prosthetics Market is Expected to Experience Immense Growth During 2020 – 2023

 The exclusive research report on the Global Robotics Prosthetics Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

The Global Robotics Prosthetics Market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 9.5% during the forecast period (2016-2027). Robotics prosthetics can be referred to as an artificial limb, which improves the lifestyle and function of a person with a missing body part.

The rising number of trauma cases and accidents and surging incidences if chronic diabetes has increased the number of amputation surgeries in the U.S.  Robotics prosthetics help to mimic the functionality and appearance of missing body parts. The type of prosthetics always depends on the stability, size, use, type, and age of the person. Thus, consumers prefer customized robotics prosthetics depending on their requirements. The soaring demand for customized prosthetics will thus drive the robotic prosthetics market in the foreseeable future.

Also Read : https://www.medgadget.com/2019/09/robotics-prosthetics-market-2019-top-companies-growth-strategies-demand-size-trends-revenue-analysis-industry-news-price-factors-and-forecast-to-2027.html 

The advent of mind-controlled humonics is considered one of the most vital robotic prosthetic trends that is likely to impact the market growth, especially in the U.S. It helps to fulfill the unmet needs of volitional control and lost sensation and development of aesthetics like gestures, which is not possible with orthopedic prosthetics. With sensory feedback technology, humonics offer mind-controlled and user-centric prosthetics, thereby providing users complete control. Such advancements are estimated to encourage the market growth in the long run.

On the contrary, robotic prosthetics are not well covered under insurance policies, which is likely to deter the market growth. Additionally, these prosthetics are expensive, thus making them inaccessible to the users. This is likely to restrict the market growth in the foreseeable future.

Key Players – Robotics Prosthetics Market

The Global Robotics Prosthetics Market is highly fragmented with the presence of many local players and international players. The main focus of these players is cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through collaborations and partnerships to expand their overall market share.

The top players operating in the robotics prosthetics market include Touch Bionics Inc. (U.S.), HDT Global Inc (U.S.), Shadow Robot Company (U.K), SynTouch, LLC (U.S.), Smith & Nephew (U.K), Stryker Corporation (U.S.), ReWalk Robotics (Israel), Aethon (U.S.), KUKA Roboter GmbH (Germany), Medrobotics Corporation (U.S.), Mazor Robotics Ltd. (Israel), Intuitive Surgical, Inc. (U.S.), Transenterix, Inc. (U.S.), Hansen Medical, Inc. (U.S.), and ZOLL Medical Corporation (U.S.).

Industry Update

August 2019: An all-new electronic skin system, Asynchronous Coded Electronic Skin is equipped with ultra-high responsiveness and is capable of pairing with any sensor skin layers in order to function efficiently as an electronic skin. This artificial nervous system can give prosthetic devices and robots a sense of touch, which is better than human skin.

June 2019: A mechatronics graduate from Simon Fraser University has designed a 3D printed humanoid robot finger that can mimic the strength and tenderness of a human hand. Robots equipped with these flexible fingers can be used to help people with mobility challenges as well as limb differences.

Regional Analysis – Robotics Prosthetics Market

Middle East & Africa, Asia Pacific, the Americas and Europe are the key markets for robotics prosthetic.

Largest portion of the robotics prosthetics market is controlled by the Americas. Robust demand for robotic prosthetics in the United States (U.S.) results in regional dominance. Government support in the form of investments for developing technologically advanced prosthetic limbs for veterans and soldiers benefits the market. The Centers for Disease Control and Prevention revealed in 2015 that the high number of osteoporosis cases as well as low bone mass at the femur neck in the U.S. are prevalent mostly in adults aged 50 years. Besides, the highest prevalence of osteoporosis has been recorded among Mexican-American adults accounting for 24.9%, with the condition affecting about 15.7% of the non-Hispanic white adults. These factors are promoting market growth in the region, MRFR reports.

Europe stands as the second-biggest market for robotics prosthetics. The market growth is in response to the growing government support with respect to research and development in the robotics prosthetics fields. France and Germany witness massive investment in the healthcare domain, which makes them the top contributing countries in the region.

Asia Pacific notes the fastest growth rate in the worldwide market. In the region, India and China could note fast-track growth on account of the expanding aging population and the mounting awareness about advanced technology. Surging amount of funds for research and development, as well as the availability of best treatment options, add to the market strength. Increasing demand for sophisticated healthcare facilities as well as gadgets also pushes market growth to a great extent. Another critical factor could be the lower cost of treatment compared to other regions.

Middle East and Africa accounts for the smallest market for robotics prosthetics due to scarce investment and substandard healthcare infrastructure.

Segmentation – Robotics Prosthetics Market

The Global Robotics Prosthetics Market has been segmented on the basis of technology, product, application, and end user.

By product, the market is segmented into prosthetic feet/ankles, prosthetic arms, prosthetic hands, prosthetic legs/knees, and others.

By technology, the market is segmented into Bluetooth, prosthetic foot materials, myoelectric technology, microprocessor knees, and others.

By application, the market comprises lower body extremity and upper body extremity.

The end users segment comprises clinics, hospitals, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/robotics-prosthetics-market-1316 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Osteoarthritis 2020 Global Market Key Players, Analysis and Forecast to 2023

 An expert on premium research reports, Market Research Future has added a report titled "Global Osteoarthritis Market 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Osteoarthritis is leads to the breakage of the joint cartilage and is one of the most common forms of arthritis. Osteoarthritis can cause immense pain, swelling, and a limited motion in affected joints. Usually, hands, knees, hips and the spine are highly probable to be affected by osteoarthritis. As per the report by Market Research Future (MRFR), the global osteoarthritis market is expected to ascend at a 6.8% CAGR through the forecast period.

Also Read : https://www.medgadget.com/2019/08/osteoarthritis-market-2019-size-trends-potential-growth-share-and-key-country-analysis-with-forecast-to-2023.html 

Some factors, as mentioned in the latest report by Market Research Future (MRFR) contributing to the ascension of the global osteoarthritis market include a rising prevalence of the geriatric population across the globe. Further, unhealthy lifestyle has led to a proliferation in the number of overweight individuals, magnifying the risk of osteoarthritis among consumers. An improvement in detection techniques has led to a rise in detection rates, driving the global osteoarthritis market. Other than that, improved accessibility to healthcare facilities has also contributed to the global osteoarthritis market growth by 2023.

Key Players for Global Osteoarthritis Market

The report has mentioned various players in the global osteoarthritis market including Abbott. (U.S.), Novartis AG (Europe), Pfizer Inc. (U.S.), Eli Lilly and Company (U.S.), ABIOGEN PHARMA S.p.A (Europe), Merck Sharp & Dohme Corp. (U.S.), TissueGene Inc. (U.S.), Ampio Pharmaceuticals Inc. (U.S.), Regeneron (U.S.).

Industry Update

June 2019: A treatment developed by biomedical engineers in the Cornell University uses a synthetic version of a joint lubricant to bind the surface of cartilage in joints. It acts as a cushion during heavy activities such as running. This treatment is currently in canine clinical trials and will be eventually used in humans.

March 2019: Researchers from the Kennedy Institute of Rheumatology at the University of Oxford, and Jenner Institute have collaboratively developed a vaccine that could be used to treat chronic pain caused by osteoarthritis. The virus-like particle vaccine is capable of triggering the immune system to produce antibodies which would help to block naturally-occurring NGF and alleviate osteoarthritis pain.

Segmental Analysis

The global osteoarthritis market is studied for various segments based on type, diagnosis, treatment, end-users, and region. Based on type, the global osteoarthritis market is segmented into hip osteoarthritis, wrist osteoarthritis, and spinal osteoarthritis. Based on end-user, the osteoarthritis market is segmented into research organization, medical institutes, and hospitals & clinics.

Based on diagnosis, the global osteoarthritis market is segmented into imaging, and joint fluid analysis. Among these segments, the imaging segment is further sub-segmented into X-rays, and magnetic resonance imaging (MRI).

Based on treatment, the osteoarthritis market is segmented into medication, surgery, and therapy. The medication segment is further sub-segmented into non-steroidal anti-inflammatory drugs and analgenics. The analgenics segment is further segmented into acetaminophen and duloxetine. The non-steroidal anti-inflammatory drugs segment is further sub-segmented into ibuprofen, aspirin, naproxen, and naproxen sodium.

Regional Analysis of Global Osteoarthritis Market

The global osteoarthritis market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. Among these segments, the Americas are expected to spearhead the global osteoarthritis market over the forecast period. This market domination can be owed to a well-developed healthcare sector and a massive patient population residing in the region. Additionally, changing lifestyle and an increasing healthcare expenditure have also contributed to the ascension of the regional osteoarthritis market.  In 2015, a report by the Centre for Disease Control and Prevention, 17.8% of US’s total GDP accounted for the country’s healthcare expenditure, which came to USD 3.2 trillion.

Europe, on the other hand is anticipated to follow the Americas and owe for the second largest osteoarthritis market during the forecast period. Such market growth can be attributed to the rising availability of funds for research and a huge patient population for osteoarthritis. Further, increasing healthcare expenditure in the region, along with a well-developed healthcare sector and government support for R&D projects are boosting growth in the regional osteoarthritis market over the review period. Western Europe is anticipated to hold the largest share in the regional osteoarthritis market with Germany, France, and the UK at the forefront. However, Eastern Europe is estimated to grow at a relatively faster rate owing to expansion opportunities for various market players.

Asia Pacific is anticipated to grow at the fastest rate during the forecast period, owing to the presence of a massive patient population and the presence of significant developing countries such as China and India. Further, humongous growth opportunities for various international and regional market players are expected to drive the market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/osteoarthritis-market-1609

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Pharmacogenomics Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Pharmacogenomics Market over the forecast period.

Pharmacogenomics Market: Segmental Analysis

The global market for pharmacogenomics has been segmented on the basis of technology, application, and end user.

The types of technology in the market include microarray, sequencing, polymerase chain reaction, and others. The sequencing segment is further segmented on the basis of Sanger sequencing, pyrosequencing, next-generation sequencing, and others.

Also Read : https://www.medgadget.com/2019/11/pharmacogenomics-market-2019-by-size-share-latest-innovation-industry-trends-growth-factors-demands-opportunities-key-players-analysis-forecast-2023.html 

The segments based on application are oncology, cardiology, neurological disorders, and others. The oncology segment can be considered for breast cancer, lung cancer, and others.

On the basis of end users, the market is segmented into hospitals, research organizations, academic institute, and others.

Market Drivers and Top Barriers

According to Market Research Future (MRFR), the Global pharmacogenomics market is projected to expand at a CAGR of 5.8% over the forecast period (2017-2023).

The deciding factors in the pharmacogenomics market growth include the surging expenditure in research and development (R&D) along with the elevating rate of adverse reactions. World over, there has been a rising focus on precision medicine coupled with the growing need for drug safety as well as efficacy, which has led to the market expansion in recent years.

On that note, the strong focus on precision medicine is striving to expand the pharmacogenomics market, as the primary aim of precision medicine is integrating genetic as well as environmental information of certain diseases along with their responses to specific treatments. This factor helps in targeted drug therapies, in addition to the growing adoption of treatment procedures that reduce the side effects and achieve accurate results, which makes extensive use of pharmacogenomics. For instance, in 2015, the United States (U.S.) government had implemented a new precision medicine initiative to augment the development of individualized care, which includes genetic variability for a variety of chronic disorders.

Additionally, the rapid growth in the number of research studies associated with sequencing, particularly next-generation sequencing, will raise the demand for pharmacogenomic tests in the years to come. This factor will play an integral role in market growth to a large extent.

Market Opportunities

Pharmacogenomics is considered to be a vital aspect in terms of cancer treatment, having proved to be a favorable option helping with the survival of patients. Over and above that, pharmacogenomics also has managed to reduce the additional cost owing to unresponsive treatment. Therefore, growing use of pharmacogenomics for the treatment of cancer has resulted in numerous significant discoveries, which is bound to contribute to the growth of the worldwide market in the upcoming period.

Pharmacogenomics Market: Competitive Analysis

• Assurex Health Inc. (U.S.),
• Pathway Genomics (U.S.),
• Teva Pharmaceutical Industries Ltd. (Israel),
• Myriad Genetics, Inc. (U.S.),
• GeneDx. (U.S.),
• Future Science Group (U.S.),
• GeneTech (U.S.),
• 23andMe, Inc. (U.S.)

Pharmacogenomics Market: Latest Industry Updates

May 2019: Premier Health Group has partnered with Navigator Genomics (NGT), in a bid to offer access to their Pharmacogenomic Testing. This testing will be for medical cannabis along with 416 of the popular medicines. This will ensure that the patients are provided with the best medical drugs, avoiding the medication that are not effective.

October 31, 2018: The U.S. Food and Drug Administration has recently announced that they have approved the marketing of 23andMe’s reports on pharmacogenetics. The genetic-testing company claims are designed to assess whether the genetics will affect an individual’s ability to metabolize certain drugs which include antidepressants.

Nov 2017: Myriad Genetics, Inc., announced positive results from a double-blind, multi-center, randomized controlled trial assessing the impact of the GeneSight Psychotropic test (GeneSight) on psychiatric treatment response in 1,200 patients with major depressive disorder. GeneSight is one of the leading pharmacogenomics test to help guide medication selection for mental health disorders.

Pharmacogenomics Market: Regional Analysis 

The pharmacogenomics market is spread across the primary regions of the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas has been identified as the dominant region in the global pharmacogenomics market, on account of highly-developed healthcare industry coupled with the inclusion of developed countries such as the United States (U.S.) as well as Canada. Furthermore, the expansion of the patient pool suffering from cardiovascular diseases as well as the growing healthcare expenditure is nurturing the growth of the regional market. As per the Centers for Diseases Control and Prevention, in 2015, heart disease had been the main cause of death for men as well as women in the U.S. In addition, the analysis suggested that the spending on healthcare for heart diseases in the country touches the valuation of USD 200 billion every year.

Data analysts concur that Europe stands second in the global pharmacogenomics market, with the Asia Pacific following suit. The surge in the funds for research and development on top of the increasing government support and the expanding patient population will prove to be instrumental in the market growth. Plus, the region also benefits from the primary contribution of the developed nations such as France and Germany with excellent growth prospects in the medical field.

Racing ahead at the fastest growth rate is the region of Asia Pacific, with the primary reasons being the burgeoning patient pool and the progressively growing economies such as India and China in the region. The Indian Brand Equity Foundation had reported in 2016 that the biotech industry in India is expected to arrive at the valuation of USD 100 billion by the year 2025, crossing the value of USD 7 billion it had reached in 2015. The industry is also expected to expand at a growth rate of 30.46% in the mentioned evaluation period, as per reports.

Meanwhile, the growth of the Middle East & Africa market has been inferior to other regions in the global pharmacogenomics market. This stunted growth can be the result of the poor economy, low expenditure on healthcare, and the rigid government policies, particularly in Africa. Concurrently, the substantial portion of the regional market is controlled by the Middle East, with the backing from the well-established healthcare industry combined with the growing healthcare expenditure. Apart from this, developed countries such as Dubai, Saudi Arabia, and Qatar have a big hand in the growth of the Middle East & Africa market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com